Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March–October, 2021

BACKGROUND: Monitoring the effectiveness of COVID-19 vaccines against SARS-CoV-2 infections remains important to inform public health responses. Estimation of vaccine effectiveness (VE) against serological evidence of SARS-CoV-2 infection might provide an alternative measure of the benefit of vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Plumb, Ian D., Fette, Lida M., Tjaden, Ashley H., Feldstein, Leora, Saydah, Sharon, Ahmed, Amina, Link-Gelles, Ruth, Wierzba, Thomas F., Berry, Andrea A., Friedman-Klabanoff, DeAnna, Larsen, Moira P., Runyon, Michael S., Ward, Lori M., Santos, Roberto P., Ward, Johnathan, Weintraub, William S., Edelstein, Sharon, Uschner, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995303/
https://www.ncbi.nlm.nih.gov/pubmed/36932031
http://dx.doi.org/10.1016/j.vaccine.2023.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995303/
https://www.ncbi.nlm.nih.gov/pubmed/36932031
http://dx.doi.org/10.1016/j.vaccine.2023.03.006

Ejemplares similares